American Herbal Products Association (AHPA) > News > AHPA in the News

AHPA in the News

Webinar: FDA's Stance on CBD

February 13, 2020 -- 12:00-1:30 PM Eastern Time

“Phase One” agreement with China provides some relief to supplement importers

Reduced tariffs will affect imports filed after February 14

A partial trade agreement signed by the United States and China on January 15, 2020, will reduce U.S.-imposed tariffs on some imported Chinese goods used by U.S. dietary supplement and food companies, but it will leave tariffs on other commodities in place, at least for the short term.

Webinar: CA Prop 65 for Legal Cannabis Products

February 26, 2020 -- 1:00-3:00 PM Eastern Time

Effective January 3, 2020, the Office of Environmental Health Hazard Assessment added cannabis (marijuana) smoke and Δ9-tetrahydrocannabinol (Δ9-THC) to the list of chemicals known to the state to cause reproductive toxicity (developmental endpoint) for purposes of California Proposition 65 (Prop65). At a public meeting on December 11, 2019, the Developmental and Reproductive Toxicant Identification Committee (DARTIC) in its official capacity as the “state’s qualified experts” determined that cannabis (marijuana) smoke and Δ9tetrahydrocannabinol (Δ9-THC) were shown to cause reproductive toxicity based on the developmental endpoint.
Dietary Supplements Regulatory Summit

Dietary Supplements Regulatory Summit

Washington, D.C.

Registration is now open for the annual Dietary Supplements Regulatory Summit (DSRS), taking place Wednesday, May 27, at the historic Mayflower Hotel in Washington, D.C. Now in its fifth year, the summit is an intimate, one-day, executive-level conference and networking event in the heart of the nation’s capital.

December 2019 AHPA in the News


Webinar: Preparing for FDA cGMP Facility Inspections

Recorded December 17, 2019

This webinar is designed to help businesses in the dietary supplement industry understand the elements of current Good Manufacturing Practice (cGMP) regulations (21 CFR 111) that have been the primary focus of FDA inspections. This knowledge will assist businesses in better allocating and directing their compliance resources.

AHPA President Michael McGuffin participates in Hemp Industry Daily Forum at MJBizCon

Compliant hemp-CBD companies can learn much from the success of the herbal supplement industry

AHPA President Michael McGuffin presented with three other panelists in a session titled, “CBD Market Forecast: Feast or Famine” at the Hemp Industry Daily Forum during the MJBizCon in Las Vegas earlier this week.

Webinar: Supplement cGMP Basics for Hemp-CBD Companies

Recorded Dec. 10, 2019 -- Duration: 2 hours

This webinar provides an overview of dietary supplement current good manufacturing (cGMP) requirements for hemp-CBD products. Legal and industry experts provide strategies and resources to comply and document compliance with  federal manufacturing requirements designed to ensure supplement product quality and safety.

Michael McGuffin named Industry Leader by Nutritional Outlook’s 2019 Best of the Industry Awards

Michael McGuffin named Industry Leader by Nutritional Outlook’s 2019 Best of the Industry Awards

McGuffin and AHPA are a leading voice not only for the herbal products industry but for the entire dietary supplement industry

Nutritional Outlook named AHPA President Michael McGuffin Industry Leader as part of the publication's 2019 Best of Industry Awards. This year, McGuffin celebrated his 20th anniversary as association president. "Under Michael's tenure—and even before that, when he served on the association’s board of trustees—AHPA has been a leading influence and guiding hand in shaping the safe, responsible, and prosperous herb commerce market that so many consumers rely on today," according to the Nutritional Outlook announcement.

November 2019 AHPA in the News


RSS
1234567

2020 Annual Fund Sponsors

   

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.